Enhanced Recovery After Surgery Program for Colorectal Cancer: a Multi-center Study (ERASC1)

  • participants needed
  • sponsor
    Jinling Hospital, China
Updated on 8 November 2020
Ping CHEN, M.D.
Primary Contact
Northern Jiangsu People's Hospital (2.0 mi away) Contact
+14 other location


This study is aimed to evaluate the safety of applying enhanced recovery after surgery for colorectal cancer.


In China, Europe and America, colorectal cancer is one of common malignant tumors. It is very important for treatment of colorectal cancer to enhance the quality of treatment, increase patients' survival rate and improve the life quality. So far, surgical resection is optimal treatment for patients with colorectal cancer. As a result, increasing the quality of surgery and improving the perioperative managements have a great influence on patients received a coloproctectomy. Investigators have spent over ten years studying enhanced recovery after surgery programs for colorectal cancer and have got some successful experience. Investigators found enhanced recovery after surgery can accelerate patients' recovery without increasing complications. This study is the first multi-center study of enhanced recovery after surgery for colorectal cancer in China. During this period, the study is aimed to evaluate the safety of applying enhanced recovery after surgery for colorectal cancer.

Treatment enhanced recovery after surgery
Clinical Study IdentifierNCT03126058
SponsorJinling Hospital, China
Last Modified on8 November 2020

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.


Yes No Not Sure

Inclusion Criteria

Is your age between 18 yrs and 75 yrs?
Gender: Male or Female
Do you have Colorectal Cancer?
Requirements of informed consent and assent of participant, parent or legal guardian as applicable
Patients with colorectal cancer scheduled for radical coloproctectomy and between the age of 18 and 75 years old without considering sex
ASA physical status I-III
Participants can follow the drug doses and visit plan

Exclusion Criteria

Patients certified by a doctor that doesn't fit to participate in this study
Patients with ischemic heart disease, cerebrovascular disease and peripheral vascular disease, or their cardiac function > II (NYHA) patients, patients received CABG recently, and patients with severe hypertension (systolic pressure180mmHg or diastolic pressure110mmHg)
Patients with colorectal cancer with distant metastasis
Patients with severe infection, respiratory dysfunction, coagulation disorders, severe liver and renal dysfunction (Child - Pugh 10; creatinine clearance < 25 ml/min)
Patients allergic to common drugs, such as opioids, non-steroidal drugs, cephalosporins, etc
Patients with operations of gastrointestinal cancer and complicated abdominal operations
Patients complicated by colorectal cancer with complications such as hemorrhage, perforation, obstruction
Patients with dyscrasia and severe malnutrition (albumin30g/L, weight loss in half a year10%, SGA classification C, BMI18, Hb70g/L)
Patients with metabolic complications caused by diabetes
Patients can't finish enhanced recovery after surgery programs and have contraindications of enhanced recovery after surgery
Pregnancy and lactation women, or have a pregnancy plan within a month after the test of the subjects (also including male participants)
Patients participated other subjects 3 months before this subject
Sponsors or researchers directly involved in the testing or their family members
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.
Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more
Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more
Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer


user name

Annotated by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No made yet